Translating Scientific Breakthroughs into Promise for Patients

From discovery through commercialization, all of us at Ardelyx are driven to advance targeted therapies where significant medical needs persist. We have developed a unique and innovative platform that has enabled the discovery of new biological mechanisms and pathways to create targeted, first-in-class, oral, small molecule therapies to meet these needs. 

With Integrity and Dedication, We Make a Difference for Patients

Join Us

We are… Passionate. Fearless. Dedicated. Inclusive!

Patients & Families

Translating scientific breakthroughs into promise for patients.

For Investors

Creating value from

Recent News

October 13, 2021

Ardelyx Provides Corporate Update Following Type A Meeting with FDA

September 3, 2021

Ardelyx Announces Publication of 52-Week Phase 3 PHREEDOM Trial

August 13, 2021

Ardelyx Reports Second Quarter 2021 Financial Results